Table 2.
Associations of AITD with cardiometabolic risk factors by linear regression.
| Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
| TPO/TgAb (+) | TPO/TgAb and US (+) | TPO/TgAb (+) | TPO/TgAb and US (+) | |||||
| B (95% CI) | P | B (95% CI) | P | B (95% CI) | P | B (95% CI) | P | |
| BMI | 0.171 (−0.186, 0.527) | 0.349 | 0.918 (0.331, 1.504) | 0.002 | 0.353 (0.112, 0.595) | 0.004 | 0.779 (0.456, 1.102) | <0.001 |
| WC | 0.097 (−0.925, 1.120) | 0.852 | 1.998 (0.321, 3.674) | 0.020 | 0.712 (0.086, 1.339) | 0.026 | 2.100 (1.263, 2.936) | <0.001 |
| HDL | −0.004 (−0.037, 0.028) | 0.792 | 0.011 (−0.042, 0.064) | 0.691 | 0.001 (−0.021, 0.022) | 0.950 | −0.004 (−0.033, 0.024) | 0.778 |
| LDL | −0.004 (−0.046, 0.006) | 0.924 | 0.021 (−0.107, 0.149) | 0.749 | 0.026 (−0.026, 0.078) | 0.331 | −0.011 (−0.081, 0.059) | 0.751 |
| TC | −0.030 (−0.150, 0.090) | 0.625 | 0.066 (−0.130, 0.262) | 0.508 | −0.017 (−0.092, 0.059) | 0.662 | −0.020 (−0.121, 0.081) | 0.700 |
| TG | −0.033 (−0.092, 0.027) | 0.281 | −0.021 (−0.119,0.076) | 0.667 | 0.032 (0.000, 0.065) | 0.052 | 0.035 (−0.009, 0.078) | 0.121 |
| HbA1c | −0.014 (−0.030, 0.002) | 0.093 | −0.004 (−0.030, 0.023) | 0.785 | 0.010 (0.001, 0.019) | 0.032 | 0.011(−0.002, 0.023) | 0.089 |
| FPG | −0.021 (−0.042, 0.000) | 0.055 | 0.006 (−0.028, 0.041) | 0.724 | −0.005 (−0.017, 0.007) | 0.444 | 0.003 (−0.013, 0.019) | 0.718 |
| HOMA-IR | −0.011 (−0.083, 0.062) | 0.771 | 0.058 (−0.061, 0.177) | 0.340 | 0.032 (−0.013, 0.077) | 0.159 | 0.071 (0.010, 0.132) | 0.021 |
| Systolic BP | −1.509 (−3.536, 0.519) | 0.145 | −1.071 (−4.418, 2.276) | 0.531 | 0.173 (−1.159, 1.505) | 0.799 | −0.309 (−2.091, 1.474) | 0.731 |
TG, HbA1c, FPG, and HOMA-IR was ln transformed for normal distribution. The regression models were adjusted for age, smoking history (including current and past), TSH, BMI (not included for BMI and WC in regression model), and menopause status in women.